The PPARβ/δ agonist GW501516 induced the expression of Glut1 (glucose transporter 1) and SLC1A5 (solute carrier family 1 member 5), which favors glucose and glutamine influx, thereby enhancing the proliferation of different cancer cell lines in vitro [78,414]. This evidence concerns the gene SLC1A5 and cancer.